Vision loss linked to depression

Article

American adults who lose their eyesight are almost twice as likely to be depressed as other adults, an analysis of data from a large federal health survey has revealed.

 

American adults who lose their eyesight are almost twice as likely to be depressed as other adults, an analysis of data from a large federal health survey has revealed.

To assess the relationship between vision and depression, researchers used data from the 2005-2008 National Health and Nutrition Examination Survey (NHANES), which included 10,480 adults. This recurring, nationally representative survey nation’s health is sponsored by the Centers for Disease Control and Prevention (CDC).

NHANES asked participants about their ability to perform 6 vision-related functional tasks such as reading a newspaper and finding items on a crowded shelf. Depression was assessed with a 9-question screening test, the Patient Health Questionnaire. The estimated weighted (crude) prevalence of depression in adults aged 20 years or older with self-reported visual function loss was 11.3% (95% confidence interval [CI], 9.7% - 13.2%) compared with 4.8% in adults without any self-reported functional impairment (95% CI, 4.0% - 5.7%).

"The uniqueness of this study is that it was done in a national sample. NHANES samples people nationally and from all adult age groups. We were not just looking at [the] Medicare population," said Jinan B. Saaddine, MD, MPH study coauthor.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
© 2025 MJH Life Sciences

All rights reserved.